Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Lumos Pharma, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 36 | 1 | 35 | 0 |
| Shares | 2.39M | 3.49K | 2.56M | +178.7K (+7.5%) |
| Value | $18.7M | $27.0K | $23.0M | +$4.25M (+22.7%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (2)
Institutions that held Lumos Pharma, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Wipfli Financial Advisors LLC, | 1,011 | $9.00K | 0.00% |
| JPMorgan Chase & Co | 29 | $0 | 0.00% |
Sold out (2)
Institutions that held Lumos Pharma, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| NEA Management Company, LLC | 65,374 | $503.0K |
| Captrust Financial Advisors | 621 | $5.00K |
Not filed for Q3 2022 yet (1)
Institutions that held Lumos Pharma, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 3,490 | $27.0K |